Anavex Life Sciences Corp (AVXL)

[jimmy667]

Looks like next news on this front will be that the Rhett Syndrome foundation will fund the trial. It would seem thatvthe duration of such a trial or the top line results would be available PDQ as it will either work or not and the effect would be easily measured or demonstrated. Dramatic results would mitigate toward accelerated approval thereby validating the platform across the board for the various indications.
One message or take a way from such a funding would say to market in effect "Who needs BP partnership our drug is so novel and so effective that funding for AVXL trials will come from foundations and grants no need for Partnership or secondary offering or even the LP credit facility" Also validates A2-73 as an upsteam curative agent not a pallative treatment as are all the current nuero drugs are pallative only many with dangerous side effects. Safe effective not just on symptoms of various Neuro indications but curative. THIS IS BIGGER THAN IT SEEMS AT FIRST BLUSH. Consider the logical extension of what this would indicate if A2-73 is effective on Rhetts and again if it works they will know soon and results could be dramatic.